Company: HURA
Filing Date: 2025-08-12
Form Type: S-1
Source: 0001193125-25-179009
Chunk: 349

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-08-12
Form: S-1
Chunk 349
---
,090 |     |   | 126,901 |
| Total stock-based compensation expense |     | $ | 1,424,736 |     | $ | 334,604 |

**Note 11-Commitments and contingencies**

Lease Commitments - The Company leases facilities under non-cancelable operating leases for the laboratory and offices in Tampa, Florida. The current lease expires in March 2026.

Future minimum lease payments under these leases are as follows:

| Year ending December 31, 2025 (9 months)   |     | $ | 130,234 |   |
| Year ending December 31, 2026              |     |   |  43,411 |   |
| Interest portion of right of use liability |     |   |  (9,051 | ) |
| Operating lease liabilities                |     | $ | 164,594 |   |

Total lease expense was approximately $ 70,000 and $ 62,000 for the three months ended March 31, 2025 and 2024, respectively.

Cash paid for amounts included in the measurement of lease liabilities was approximately $ 43,000 and $ 33,000 for the three months ended March 31, 2025 and 2024.

For the current lease, the weighted-average lease term is 1.00 years and 2.00 years and the weighted average discount rate is 10.0 % and 10.0 % as of March 31, 2025 and 2024

Employment Agreements - The Company maintains employment agreements with its Chief Executive Officer and Chief Financial Officer, each entered into in May 2023 by Legacy TuHURA and as subsequently assumed by the Company in connection with the closing of the Kintara Merger.

<div align='center'>F-105</div>

Future minimum payments under these employment agreements are as follows:

| Year ending December 31, 2025 (9 months) |     | $ |   655,500 |
| Year ending December 31, 2026            |     |   |   874,000 |
|                                          |     | $ | 1,529,500 |

Note 12-Subsequentevents Subsequent events -The Company has evaluated subsequent events through May 15, 2025 in connection with the preparation of these unaudited interim consolidated financial statements, which is the date they were available to be issued. Merger Agreement Amendment with Kineta On May